AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

TRIPTORELINE

9 registrations across 3 African markets— 5 active

Markets with TRIPTORELINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
DECAPEPTYL 11,25MG IM POUDRE POUR SUSPENSION INJECTABLE A LIBERATION PROLONGEE BOITE DE 1🇨🇮Côte d'IvoireIPSEN PHARMAactiveJul 2028
DECAPEPTYL 3,75MG IM POUDRE POUR SUSPENSION INJECTABLE A LIBERATION PROLONGEE BOITE DE 1🇨🇮Côte d'IvoireIPSEN PHARMAactiveJan 2027
GONAPEPTYL
Pdre p.prep.injectable / 3.75 mg
🇹🇳TunisiaFERRING S.A.SexpiredJul 2012
DECAPEPTYL LP
Pdre p.prep.injectable / 11.25 mg
🇹🇳TunisiaIPSEN PharmaexpiredMay 2003
DECAPEPTYL LP
Pdre p.prep.injectable / 3 mg
🇹🇳TunisiaIPSEN PharmaexpiredMar 2002
DECAPEPTYL SC
Solution injectable / 0.1 MG
🇹🇳TunisiaIPSEN PharmaexpiredSept 1999
DECAPEPTYL
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
DECAPEPTYL LP
POUDRE POUR SOLUTION INJECTABLE
🇲🇦Moroccoactive
DECAPEPTYL LP
POUDRE POUR SUSPENSION INJECTABLE
🇲🇦Moroccoactive

TRIPTORELINE in Africa — Regulatory Overview

TRIPTORELINE is registered across 3 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Côte d'Ivoire. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 5 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.